Organic cation transporters

被引:214
作者
Koepsell, H. [1 ]
Schmitt, B. M. [1 ]
Gorboulev, V. [1 ]
机构
[1] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany
来源
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 150 | 2004年 / 150卷
关键词
D O I
10.1007/s10254-003-0017-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Over the last 15 years, a number of transporters that translocate organic cations were characterized functionally and also identified on the molecular level. Organic cations include endogenous compounds such as monoamine neurotransmitters, choline, and coenzymes, but also numerous drugs and xenobiotics. Some of the cloned organic cation transporters accept one main substrate or structurally similar compounds (oligospecific transporters), while others translocate a variety of structurally diverse organic cations (polyspecific transporters). This review provides a survey of cloned organic cation transporters and tentative models that illustrate how different types of organic cation transporters, expressed at specific subcellular sites in hepatocytes and renal proximal tubular cells, are assembled into an integrated functional framework. We briefly describe oligospecific Na+- and Cl--dependent monoamine neurotransmitter transporters (SLC6-family), high-affinity choline transporters (SLC5-family), and high-affinity thiamine transporters (SLC19-family), as well as polyspecific transporters that translocate some organic cations next to their preferred, noncationic substrates. The polyspecific cation transporters of the SLC22 family including the subtypes OCT1-3 and OCTN1-2 are presented in detail, covering the current knowledge about distribution, substrate specificity, and recent data on their electrical properties and regulation. Moreover, we discuss artificial and spontaneous mutations of transporters of the SLC22 family that provide novel insight as to the function of specific protein domains. Finally, we discuss the clinical potential of the increasing knowledge about polymorphisms and mutations in polyspecific organic cation transporters.
引用
收藏
页码:36 / 90
页数:55
相关论文
共 315 条
[81]   Cloning and characterization of two human polyspecific organic cation transporters [J].
Gorboulev, V ;
Ulzheimer, JC ;
Akhoundova, A ;
UlzheimerTeuber, I ;
Karbach, U ;
Quester, S ;
Baumann, C ;
Lang, F ;
Busch, AE ;
Koepsell, H .
DNA AND CELL BIOLOGY, 1997, 16 (07) :871-881
[82]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[83]  
GRAEFE KH, 1988, HDB EXPT PHARM CATEC, V1, P193
[84]   THE SUBSTRATE-SPECIFICITY OF UPTAKE2 IN THE RAT-HEART [J].
GROHMANN, M ;
TRENDELENBURG, U .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 328 (02) :164-173
[85]   Functional impairment of renal organic cation transport in experimental diabetes [J].
Grover, B ;
Auberger, C ;
Sarangarajan, R ;
Cacini, W .
PHARMACOLOGY & TOXICOLOGY, 2002, 90 (04) :181-186
[86]   Gene structures of the human non-neuronal monoamine transporters EMT and OCT2 [J].
Gründemann, D ;
Schömig, E .
HUMAN GENETICS, 2000, 106 (06) :627-635
[87]   Transport of monoamine transmitters by the organic cation transporter type 2, OCT2 [J].
Gründemann, D ;
Köster, S ;
Kiefer, N ;
Breidert, T ;
Engelhardt, M ;
Spitzenberger, F ;
Obermüller, N ;
Schömig, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) :30915-30920
[88]  
Grundemann D, 1997, J BIOL CHEM, V272, P10408
[89]   Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter [J].
Grundemann, D ;
Schechinger, B ;
Rappold, GA ;
Schomig, E .
NATURE NEUROSCIENCE, 1998, 1 (05) :349-351
[90]   Selective substrates for non-neuronal monoamine transporters [J].
Gründemann, D ;
Liebich, G ;
Kiefer, N ;
Köster, S ;
Schömig, E .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :1-10